These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6180100)

  • 21. Pulmonary localization of intravenously injected liposomes.
    Fidler IJ; Raz A; Fogler WE; Poste G
    Recent Results Cancer Res; 1980; 75():246-51. PubMed ID: 7232836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of lipid composition on the antitumor activity exerted by doxorubicin-containing liposomes in a rat solid tumor model.
    Storm G; Roerdink FH; Steerenberg PA; de Jong WH; Crommelin DJ
    Cancer Res; 1987 Jul; 47(13):3366-72. PubMed ID: 3581073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective enhancement of pentamidine uptake in the lung by aerosolization and delivery in liposomes.
    Debs RJ; Straubinger RM; Brunette EN; Lin JM; Lin EJ; Montgomery AB; Friend DS; Papahadjopoulos DP
    Am Rev Respir Dis; 1987 Mar; 135(3):731-7. PubMed ID: 3826898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphatic absorption and tissue disposition of liposome-entrapped [14C]adriamycin following intraperitoneal administration to rats.
    Parker RJ; Hartman KD; Sieber SM
    Cancer Res; 1981 Apr; 41(4):1311-7. PubMed ID: 7214320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liposome entrapment enhances the hypocalcemic action of parenterally administered calcitonin.
    Fukunaga M; Miller MM; Hostetler KY; Deftos LJ
    Endocrinology; 1984 Aug; 115(2):757-61. PubMed ID: 6745179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Manipulation of the surface pegylation in combination with reduced vesicle size of cationic liposomal adjuvants modifies their clearance kinetics from the injection site, and the rate and type of T cell response.
    Kaur R; Bramwell VW; Kirby DJ; Perrie Y
    J Control Release; 2012 Dec; 164(3):331-7. PubMed ID: 22800572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Protein-containing liposomes and their organ distribution following intravenous administration].
    Davidenkova EF; Rozenberg OA; Shvarts EI; Ketlinskiĭ SA
    Biull Eksp Biol Med; 1978 Jun; 85(6):673-5. PubMed ID: 667343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved pharmacological profile of the lipophilic antitumor dichloro-(N-dodecyl)-propanediamine-platinum(II) complex after incorporation into pegylated liposomes.
    Silva H; Silva AC; Lemos FO; Monte-Neto RL; Fontes AP; Lopes MT; Frézard F
    Anticancer Drugs; 2013 Feb; 24(2):131-9. PubMed ID: 23011234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measurement of carbon clearance in mice as toxicity parameter for liposomal preparations.
    Fichtner I; Kniest A; Arndt D
    In Vivo; 1992; 6(1):113-7. PubMed ID: 1627737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined liposomal immuno- and chemotherapy of visceral leishmaniasis.
    Everlien H; Hockertz S
    Arzneimittelforschung; 1999 Nov; 49(11):954-61. PubMed ID: 10604050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on the tissue distribution of liposome-associated clofazimine, an antileprosy drug.
    Sritharan M
    Methods Find Exp Clin Pharmacol; 1993 Mar; 15(2):107-11. PubMed ID: 8487593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liposomal cyclosporine. Comparison of drug and lipid carrier pharmacokinetics and biodistribution.
    Choice E; Masin D; Bally MB; Meloche M; Madden TD
    Transplantation; 1995 Nov; 60(9):1006-11. PubMed ID: 7491673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liposomal topotecan formulation with a low polyethylene glycol grafting density: pharmacokinetics and antitumour activity.
    Li C; Wang C; Yang H; Zhao X; Wei N; Cui J
    J Pharm Pharmacol; 2012 Mar; 64(3):372-82. PubMed ID: 22309269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of route of administration on the disposition of inulin encapsulated in multilamellar vesicles of defined particle size.
    Jackson AJ
    Res Commun Chem Pathol Pharmacol; 1980 Feb; 27(2):293-304. PubMed ID: 7367749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison between multilamellar and unilamellar liposomes in enhancing antibody formation.
    Shek PN; Yung BY; Stanacev NZ
    Immunology; 1983 May; 49(1):37-44. PubMed ID: 6341213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanistic studies of sequential injection of cationic liposome and plasmid DNA.
    Zhang JS; Liu F; Conwell CC; Tan Y; Huang L
    Mol Ther; 2006 Feb; 13(2):429-37. PubMed ID: 16242997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of adriamycin delivery to liver metastatic cells with increased tumoricidal effect using liposomes as drug carriers.
    Gabizon A; Goren D; Fuks Z; Barenholz Y; Dagan A; Meshorer A
    Cancer Res; 1983 Oct; 43(10):4730-5. PubMed ID: 6883331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High lung uptake of 99mTc-multilamellar liposomes after intravenous administration in rats and rabbits.
    Ninio S; Yamboliev I; Kovacheva S
    Pharmazie; 1994 May; 49(5):353-6. PubMed ID: 8016181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intramuscular absorption and regional lymphatic uptake of liposome-entrapped inulin.
    Jackson AJ
    Drug Metab Dispos; 1981; 9(6):535-40. PubMed ID: 6120812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferon induction by poly (I): poly (C) enclosed in phospholipid particles.
    Straub SX; Garry RF; Magee WE
    Infect Immun; 1974 Oct; 10(4):783-92. PubMed ID: 4426708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.